Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 269

1.

Hemochromatosis proteins are dispensable for the acute hepcidin response to BMP2.

Pagani A, Pettinato M, Colucci S, Dulja A, Rauner M, Nai A, Camaschella C, Altamura S, Muckenthaler MU, Silvestri L.

Haematologica. 2020 Feb 13. pii: haematol.2019.241984. doi: 10.3324/haematol.2019.241984. [Epub ahead of print] No abstract available.

2.

Iron metabolism and iron disorders revisited in the hepcidin era.

Camaschella C, Nai A, Silvestri L.

Haematologica. 2020 Jan 31;105(2):260-272. doi: 10.3324/haematol.2019.232124. Print 2020. Review.

3.

Hepcidin and Anemia: A Tight Relationship.

Pagani A, Nai A, Silvestri L, Camaschella C.

Front Physiol. 2019 Oct 9;10:1294. doi: 10.3389/fphys.2019.01294. eCollection 2019. Review.

4.

GDF11 is not the target of luspatercept.

Camaschella C.

Blood. 2019 Aug 8;134(6):500-501. doi: 10.1182/blood.2019001983. No abstract available.

PMID:
31395583
5.

Iron deficiency.

Camaschella C.

Blood. 2019 Jan 3;133(1):30-39. doi: 10.1182/blood-2018-05-815944. Epub 2018 Nov 6. Review.

PMID:
30401704
6.

Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice.

Artuso I, Pettinato M, Nai A, Pagani A, Sardo U, Billoré B, Lidonnici MR, Bennett C, Mandelli G, Pasricha SR, Ferrari G, Camaschella C, Kautz L, Silvestri L.

Haematologica. 2019 Mar;104(3):e87-e90. doi: 10.3324/haematol.2018.199810. Epub 2018 Sep 28. No abstract available.

7.

Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model.

Artuso I, Lidonnici MR, Altamura S, Mandelli G, Pettinato M, Muckenthaler MU, Silvestri L, Ferrari G, Camaschella C, Nai A.

Blood. 2018 Nov 22;132(21):2286-2297. doi: 10.1182/blood-2018-05-852277. Epub 2018 Sep 12. Erratum in: Blood. 2019 Jul 4;134(1):94.

8.

Advances in understanding iron metabolism and its crosstalk with erythropoiesis.

Camaschella C, Pagani A.

Br J Haematol. 2018 Aug;182(4):481-494. doi: 10.1111/bjh.15403. Epub 2018 Jun 25. Review.

PMID:
29938779
9.

A severe hemojuvelin mutation leading to late onset of HFE2-hemochromatosis.

Ravasi G, Pelucchi S, Mariani R, Silvestri L, Camaschella C, Piperno A.

Dig Liver Dis. 2018 Aug;50(8):859-862. doi: 10.1016/j.dld.2018.04.018. Epub 2018 Apr 27. No abstract available.

PMID:
29764732
10.

Anemia in the Elderly.

Girelli D, Marchi G, Camaschella C.

Hemasphere. 2018 Apr 17;2(3):e40. doi: 10.1097/HS9.0000000000000040. eCollection 2018 Jun. Review.

11.

Eliezer Rachmilewitz (1935-2017).

Cabantchik I, Muckenthaler M, Camaschella C.

Hemasphere. 2018 Feb 14;2(1):e21. doi: 10.1097/HS9.0000000000000021. eCollection 2018 Jan-Feb. Review. No abstract available.

12.

The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes.

Colucci S, Pagani A, Pettinato M, Artuso I, Nai A, Camaschella C, Silvestri L.

Blood. 2017 Nov 9;130(19):2111-2120. doi: 10.1182/blood-2017-04-780692. Epub 2017 Sep 1.

13.

Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management.

Cappellini MD, Comin-Colet J, de Francisco A, Dignass A, Doehner W, Lam CS, Macdougall IC, Rogler G, Camaschella C, Kadir R, Kassebaum NJ, Spahn DR, Taher AT, Musallam KM; IRON CORE Group.

Am J Hematol. 2017 Oct;92(10):1068-1078. doi: 10.1002/ajh.24820. Epub 2017 Jul 7. Review.

14.

A new form of IRIDA due to combined heterozygous mutations of TMPRSS6 and ACVR1A encoding the BMP receptor ALK2.

Pagani A, Colucci S, Bocciardi R, Bertamino M, Dufour C, Ravazzolo R, Silvestri L, Camaschella C.

Blood. 2017 Jun 22;129(25):3392-3395. doi: 10.1182/blood-2017-03-773481. Epub 2017 May 5. No abstract available.

15.

Clinical significance of somatic mutation in unexplained blood cytopenia.

Malcovati L, Gallì A, Travaglino E, Ambaglio I, Rizzo E, Molteni E, Elena C, Ferretti VV, Catricalà S, Bono E, Todisco G, Bianchessi A, Rumi E, Zibellini S, Pietra D, Boveri E, Camaschella C, Toniolo D, Papaemmanuil E, Ogawa S, Cazzola M.

Blood. 2017 Jun 22;129(25):3371-3378. doi: 10.1182/blood-2017-01-763425. Epub 2017 Apr 19.

16.

New insights into iron deficiency and iron deficiency anemia.

Camaschella C.

Blood Rev. 2017 Jul;31(4):225-233. doi: 10.1016/j.blre.2017.02.004. Epub 2017 Feb 13. Review.

PMID:
28216263
17.

Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma.

Bordini J, Galvan S, Ponzoni M, Bertilaccio MT, Chesi M, Bergsagel PL, Camaschella C, Campanella A.

Leukemia. 2017 Apr;31(4):967-970. doi: 10.1038/leu.2016.346. Epub 2016 Nov 24. No abstract available.

PMID:
27881873
18.

Meta-GWAS and Meta-Analysis of Exome Array Studies Do Not Reveal Genetic Determinants of Serum Hepcidin.

Galesloot TE, Verweij N, Traglia M, Barbieri C, van Dijk F, Geurts-Moespot AJ, Girelli D, Kiemeney LA, Sweep FC, Swertz MA, van der Meer P, Camaschella C, Toniolo D, Vermeulen SH, van der Harst P, Swinkels DW.

PLoS One. 2016 Nov 15;11(11):e0166628. doi: 10.1371/journal.pone.0166628. eCollection 2016.

19.

The Repair of Skeletal Muscle Requires Iron Recycling through Macrophage Ferroportin.

Corna G, Caserta I, Monno A, Apostoli P, Manfredi AA, Camaschella C, Rovere-Querini P.

J Immunol. 2016 Sep 1;197(5):1914-25. doi: 10.4049/jimmunol.1501417. Epub 2016 Jul 27.

20.

The mutual control of iron and erythropoiesis.

Camaschella C, Pagani A, Nai A, Silvestri L.

Int J Lab Hematol. 2016 May;38 Suppl 1:20-6. doi: 10.1111/ijlh.12505. Epub 2016 May 9. Review.

PMID:
27161430
21.

Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.

Nai A, Rubio A, Campanella A, Gourbeyre O, Artuso I, Bordini J, Gineste A, Latour C, Besson-Fournier C, Lin HY, Coppin H, Roth MP, Camaschella C, Silvestri L, Meynard D.

Blood. 2016 May 12;127(19):2327-36. doi: 10.1182/blood-2015-11-681494. Epub 2016 Jan 11.

22.

Iron deficiency: new insights into diagnosis and treatment.

Camaschella C.

Hematology Am Soc Hematol Educ Program. 2015;2015:8-13. doi: 10.1182/asheducation-2015.1.8. Review.

PMID:
26637694
23.

Ineffective erythropoiesis and regulation of iron status in iron loading anaemias.

Camaschella C, Nai A.

Br J Haematol. 2016 Feb;172(4):512-23. doi: 10.1111/bjh.13820. Epub 2015 Oct 22. Review.

PMID:
26491866
24.

Transferrin receptor 2 mutations in patients with juvenile hemochromatosis phenotype.

Ravasi G, Rausa M, Pelucchi S, Arosio C, Greni F, Mariani R, Pelloni I, Silvestri L, Pineda P, Camaschella C, Piperno A.

Am J Hematol. 2015 Dec;90(12):E226-7. doi: 10.1002/ajh.24202. Epub 2015 Nov 17. No abstract available.

25.

Comment on: PACE4 (PCSK6): another proprotein convertase linked to iron homeostasis?

Pagani A, Ladli M, Nai A, Verdier F, Camaschella C, Silvestri L.

Haematologica. 2015 Sep;100(9):e380. doi: 10.3324/haematol.2015.128348. No abstract available.

26.

Iron-Deficiency Anemia.

Camaschella C.

N Engl J Med. 2015 Jul 30;373(5):485-6. doi: 10.1056/NEJMc1507104. No abstract available.

PMID:
26222573
27.

Functional Analysis of GLRX5 Mutants Reveals Distinct Functionalities of GLRX5 Protein.

Liu G, Wang Y, Anderson GJ, Camaschella C, Chang Y, Nie G.

J Cell Biochem. 2016 Jan;117(1):207-17. doi: 10.1002/jcb.25267.

PMID:
26100117
28.

Iron-deficiency anemia.

Camaschella C.

N Engl J Med. 2015 May 7;372(19):1832-43. doi: 10.1056/NEJMra1401038. Review. No abstract available.

PMID:
25946282
29.

Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?

Rausa M, Pagani A, Nai A, Campanella A, Gilberti ME, Apostoli P, Camaschella C, Silvestri L.

PLoS One. 2015 Apr 10;10(4):e0122696. doi: 10.1371/journal.pone.0122696. eCollection 2015.

30.

Corrigendum: Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis.

Benyamin B, Esko T, Ried JS, Radhakrishnan A, Vermeulen SH, Traglia M, Gögele M, Anderson D, Broer L, Podmore C, Luan J, Kutalik Z, Sanna S, van der Meer P, Tanaka T, Wang F, Westra HJ, Franke L, Mihailov E, Milani L, Hälldin J, Winkelmann J, Meitinger T, Thiery J, Peters A, Waldenberger M, Rendon A, Jolley J, Sambrook J, Kiemeney LA, Sweep FC, Sala CF, Schwienbacher C, Pichler I, Hui J, Demirkan A, Isaacs A, Amin N, Steri M, Waeber G, Verweij N, Powell JE, Nyholt DR, Heath AC, Madden PAF, Visscher PM, Wright MJ, Montgomery GW, Martin NG, Hernandez D, Bandinelli S, van der Harst P, Uda M, Vollenweider P, Scott RA, Langenberg C, Wareham NJ, van Duijn C, Beilby J, Pramstaller PP, Hicks AA, Ouwehand WH, Oexle K, Gieger C, Metspalu A, Camaschella C, Toniolo D, Swinkels DW, Whitfield JB.

Nat Commun. 2015 Mar 30;6:6542. doi: 10.1038/ncomms7542. No abstract available.

31.

Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma.

Bordini J, Bertilaccio MT, Ponzoni M, Fermo I, Chesi M, Bergsagel PL, Camaschella C, Campanella A.

Haematologica. 2015 Jun;100(6):834-841. doi: 10.3324/haematol.2014.118000. Epub 2015 Feb 24.

32.

Identification of TMPRSS6 cleavage sites of hemojuvelin.

Rausa M, Ghitti M, Pagani A, Nai A, Campanella A, Musco G, Camaschella C, Silvestri L.

J Cell Mol Med. 2015 Apr;19(4):879-88. doi: 10.1111/jcmm.12462. Epub 2015 Feb 22.

33.

Regulation of cell surface transferrin receptor-2 by iron-dependent cleavage and release of a soluble form.

Pagani A, Vieillevoye M, Nai A, Rausa M, Ladli M, Lacombe C, Mayeux P, Verdier F, Camaschella C, Silvestri L.

Haematologica. 2015 Apr;100(4):458-65. doi: 10.3324/haematol.2014.118521. Epub 2015 Jan 30.

34.

The second transferrin receptor regulates red blood cell production in mice.

Nai A, Lidonnici MR, Rausa M, Mandelli G, Pagani A, Silvestri L, Ferrari G, Camaschella C.

Blood. 2015 Feb 12;125(7):1170-9. doi: 10.1182/blood-2014-08-596254. Epub 2014 Dec 11.

35.

Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis.

Benyamin B, Esko T, Ried JS, Radhakrishnan A, Vermeulen SH, Traglia M, Gögele M, Anderson D, Broer L, Podmore C, Luan J, Kutalik Z, Sanna S, van der Meer P, Tanaka T, Wang F, Westra HJ, Franke L, Mihailov E, Milani L, Hälldin J, Winkelmann J, Meitinger T, Thiery J, Peters A, Waldenberger M, Rendon A, Jolley J, Sambrook J, Kiemeney LA, Sweep FC, Sala CF, Schwienbacher C, Pichler I, Hui J, Demirkan A, Isaacs A, Amin N, Steri M, Waeber G, Verweij N, Powell JE, Nyholt DR, Heath AC, Madden PA, Visscher PM, Wright MJ, Montgomery GW, Martin NG, Hernandez D, Bandinelli S, van der Harst P, Uda M, Vollenweider P, Scott RA, Langenberg C, Wareham NJ; InterAct Consortium, van Duijn C, Beilby J, Pramstaller PP, Hicks AA, Ouwehand WH, Oexle K, Gieger C, Metspalu A, Camaschella C, Toniolo D, Swinkels DW, Whitfield JB.

Nat Commun. 2014 Oct 29;5:4926. doi: 10.1038/ncomms5926. Erratum in: Nat Commun. 2015;6:6542. Häldin, Jonas [corrected to Hälldin, Jonas].

36.

Heterozygous missense mutations in the GLRX5 gene cause sideroblastic anemia in a Chinese patient.

Liu G, Guo S, Anderson GJ, Camaschella C, Han B, Nie G.

Blood. 2014 Oct 23;124(17):2750-1. doi: 10.1182/blood-2014-08-598508. No abstract available.

PMID:
25342667
37.

Functional and clinical impact of novel TMPRSS6 variants in iron-refractory iron-deficiency anemia patients and genotype-phenotype studies.

De Falco L, Silvestri L, Kannengiesser C, Morán E, Oudin C, Rausa M, Bruno M, Aranda J, Argiles B, Yenicesu I, Falcon-Rodriguez M, Yilmaz-Keskin E, Kocak U, Beaumont C, Camaschella C, Iolascon A, Grandchamp B, Sanchez M.

Hum Mutat. 2014 Nov;35(11):1321-9. doi: 10.1002/humu.22632. Epub 2014 Sep 10.

PMID:
25156943
38.

The extrahepatic role of TFR2 in iron homeostasis.

Silvestri L, Nai A, Pagani A, Camaschella C.

Front Pharmacol. 2014 May 7;5:93. doi: 10.3389/fphar.2014.00093. eCollection 2014. Review.

39.

The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice.

Nai A, Pellegrino RM, Rausa M, Pagani A, Boero M, Silvestri L, Saglio G, Roetto A, Camaschella C.

Haematologica. 2014 Jun;99(6):1016-21. doi: 10.3324/haematol.2013.103143. Epub 2014 Mar 21.

40.

Mutation spectrum in Chinese patients affected by congenital sideroblastic anemia and a search for a genotype-phenotype relationship.

Liu G, Guo S, Kang H, Zhang F, Hu Y, Wang L, Li M, Ru Y, Camaschella C, Han B, Nie G.

Haematologica. 2013 Dec;98(12):e158-60. doi: 10.3324/haematol.2013.095513. No abstract available.

41.

Iron and hepcidin: a story of recycling and balance.

Camaschella C.

Hematology Am Soc Hematol Educ Program. 2013;2013:1-8. doi: 10.1182/asheducation-2013.1.1.

PMID:
24319154
42.

Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer.

Orlandi R, De Bortoli M, Ciniselli CM, Vaghi E, Caccia D, Garrisi V, Pizzamiglio S, Veneroni S, Bonini C, Agresti R, Daidone MG, Morelli D, Camaschella C, Verderio P, Bongarzone I.

Ann Oncol. 2014 Feb;25(2):352-7. doi: 10.1093/annonc/mdt490. Epub 2013 Dec 3.

43.

How I treat unexplained refractory iron deficiency anemia.

Hershko C, Camaschella C.

Blood. 2014 Jan 16;123(3):326-33. doi: 10.1182/blood-2013-10-512624. Epub 2013 Nov 8.

PMID:
24215034
44.

Genome wide association analysis of a founder population identified TAF3 as a gene for MCHC in humans.

Pistis G, Okonkwo SU, Traglia M, Sala C, Shin SY, Masciullo C, Buetti I, Massacane R, Mangino M, Thein SL, Spector TD, Ganesh S; CHARGE Consortium Hematology Working, Pirastu N, Gasparini P, Soranzo N, Camaschella C, Hart D, Green MR, Toniolo D.

PLoS One. 2013 Jul 31;8(7):e69206. doi: 10.1371/journal.pone.0069206. Print 2013.

45.

A strong anti-inflammatory signature revealed by liver transcription profiling of Tmprss6-/- mice.

Riba M, Rausa M, Sorosina M, Cittaro D, Garcia Manteiga JM, Nai A, Pagani A, Martinelli-Boneschi F, Stupka E, Camaschella C, Silvestri L.

PLoS One. 2013 Jul 29;8(7):e69694. doi: 10.1371/journal.pone.0069694. Print 2013.

46.

Correction: Increased Serum Hepcidin Levels in Subjects with the Metabolic Syndrome: A Population Study.

Martinelli N, Traglia M, Campostrini N, Biino G, Corbella M, Sala C, Busti F, Masciullo C, Manna D, Previtali S, Castagna A, Pistis G, Olivieri O, Toniolo D, Camaschella C, Girelli D.

PLoS One. 2013 Jun 26;8(6). doi: 10.1371/annotation/233a5ac3-8118-4bdc-a139-950223506864. Print 2013.

47.

Treating iron overload.

Camaschella C.

N Engl J Med. 2013 Jun 13;368(24):2325-7. doi: 10.1056/NEJMcibr1304338. No abstract available.

PMID:
23758239
48.

Iron refractory iron deficiency anemia.

De Falco L, Sanchez M, Silvestri L, Kannengiesser C, Muckenthaler MU, Iolascon A, Gouya L, Camaschella C, Beaumont C.

Haematologica. 2013 Jun;98(6):845-53. doi: 10.3324/haematol.2012.075515. Review.

49.

How to assess causality of TMPRSS6 mutations?

Silvestri L, Rausa M, Pagani A, Nai A, Camaschella C.

Hum Mutat. 2013 Jul;34(7):1043-5. doi: 10.1002/humu.22321. Epub 2013 Apr 17. No abstract available.

PMID:
23554218
50.

The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis.

Pelusi S, Girelli D, Rametta R, Campostrini N, Alfieri C, Traglia M, Dongiovanni P, Como G, Toniolo D, Camaschella C, Messa P, Fargion S, Valenti L.

BMC Nephrol. 2013 Feb 22;14:48. doi: 10.1186/1471-2369-14-48.

Supplemental Content

Loading ...
Support Center